ENVB
Price
$0.66
Change
-$0.02 (-2.94%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
4.15M
Intraday Buy/Sell Signals
SLNCF
Price
$1.60
Change
-$0.40 (-20.00%)
Updated
Oct 21 closing price
Capitalization
226.72M
Intraday Buy/Sell Signals
Interact to see
Advertisement

ENVB vs SLNCF

Header iconENVB vs SLNCF Comparison
Open Charts ENVB vs SLNCFBanner chart's image
Enveric Biosciences
Price$0.66
Change-$0.02 (-2.94%)
Volume$520
Capitalization4.15M
Silence Therapeutics
Price$1.60
Change-$0.40 (-20.00%)
Volume$100
Capitalization226.72M
ENVB vs SLNCF Comparison Chart in %
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. SLNCF commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Buy and SLNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 23, 2025
Stock price -- (ENVB: $0.67 vs. SLNCF: $1.60)
Brand notoriety: ENVB and SLNCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 40% vs. SLNCF: 16%
Market capitalization -- ENVB: $4.15M vs. SLNCF: $226.72M
ENVB [@Biotechnology] is valued at $4.15M. SLNCF’s [@Biotechnology] market capitalization is $226.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whileSLNCF’s FA Score has 1 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • SLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENVB and SLNCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 4 TA indicator(s) are bullish while SLNCF’s TA Score has 4 bullish TA indicator(s).

  • ENVB’s TA Score: 4 bullish, 4 bearish.
  • SLNCF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ENVB and SLNCF are a good buy in the short-term.

Price Growth

ENVB (@Biotechnology) experienced а -25.85% price change this week, while SLNCF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was +10.37%, and the average quarterly price growth was +61.79%.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNCF($227M) has a higher market cap than ENVB($4.15M). SLNCF YTD gains are higher at: -39.048 vs. ENVB (-87.586). ENVB has higher annual earnings (EBITDA): -9.68M vs. SLNCF (-84.82M). SLNCF has more cash in the bank: 114M vs. ENVB (2.85M). ENVB (0) and SLNCF (0) have identical debt. SLNCF has higher revenues than ENVB: SLNCF (27.2M) vs ENVB (0).
ENVBSLNCFENVB / SLNCF
Capitalization4.15M227M2%
EBITDA-9.68M-84.82M11%
Gain YTD-87.586-39.048224%
P/E RatioN/AN/A-
Revenue027.2M-
Total Cash2.85M114M3%
Total Debt00-
FUNDAMENTALS RATINGS
ENVB vs SLNCF: Fundamental Ratings
ENVB
SLNCF
OUTLOOK RATING
1..100
293
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6540
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
813

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (19) in the Electronics Or Appliances industry is in the same range as SLNCF (24) in the null industry. This means that ENVB’s stock grew similarly to SLNCF’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as SLNCF (100) in the null industry. This means that ENVB’s stock grew similarly to SLNCF’s over the last 12 months.

SLNCF's SMR Rating (98) in the null industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

SLNCF's Price Growth Rating (40) in the null industry is in the same range as ENVB (65) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

SLNCF's P/E Growth Rating (100) in the null industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBSLNCF
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROIV17.960.09
+0.50%
Roivant Sciences Ltd
CERO2.01N/A
N/A
CERO Therapeutics Holdings Inc
ADV1.44-0.01
-0.69%
Advantage Solutions
FRME36.61-0.31
-0.84%
First Merchants Corp
FBIO2.54-0.23
-8.30%
Fortress Biotech

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
-1.64%
RNXT - SLNCF
24%
Poorly correlated
-5.04%
QLGN - SLNCF
21%
Poorly correlated
-12.30%
SOLTF - SLNCF
9%
Poorly correlated
+2.67%
PVCT - SLNCF
8%
Poorly correlated
-5.30%
More